ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC11130-5mg |
|
753498-25-8 |
Indacaterol Maleate
|
0 | C24H28N2O3.C4H4O4 | |
GC11128-250mg |
|
120447-62-3 |
(±)-Vesamicol hydrochloride
|
0 | C17H25NO.HCl | |
GC11127-500g |
|
6080-58-6 |
Lithium Citrate
|
0 | C6H5O7.4H2O.3Li | |
GC11127-100g |
|
6080-58-6 |
Lithium Citrate
|
0 | C6H5O7.4H2O.3Li | |
GC11126-50mg |
|
1421373-62-7 |
Mutant EGFR inhibitor
|
0 | C27H30ClN7O2 | |
GC11126-10mg |
|
1421373-62-7 |
Mutant EGFR inhibitor
|
0 | C27H30ClN7O2 | |
GC11126-5mg |
|
1421373-62-7 |
Mutant EGFR inhibitor
|
0 | C27H30ClN7O2 | |
GC11125-5mg |
|
142439-95-0 |
Sp-Cyclic AMPS (sodium salt)
|
0 | C10H11N5O5PS • Na | |
GC11125-1mg |
|
142439-95-0 |
Sp-Cyclic AMPS (sodium salt)
|
0 | C10H11N5O5PS • Na | |
GC11124-50mg |
|
153322-05-5 |
Lanicemine
|
0 | C13H14N2 | |
GC11124-25mg |
|
153322-05-5 |
Lanicemine
|
0 | C13H14N2 | |
GC11124-10mg |
|
153322-05-5 |
Lanicemine
|
0 | C13H14N2 | |
GC11124-5mg |
|
153322-05-5 |
Lanicemine
|
0 | C13H14N2 | |
GC11123-25mg |
|
4072-32-6 |
α-CEHC
|
0 | C16H22O4 | |
GC11123-10mg |
|
4072-32-6 |
α-CEHC
|
0 | C16H22O4 | |
GC11123-5mg |
|
4072-32-6 |
α-CEHC
|
0 | C16H22O4 | |
GC11123-1mg |
|
4072-32-6 |
α-CEHC
|
0 | C16H22O4 | |
GC11122-10mg |
|
346673-06-1 |
TCS 2510
|
0 | C21H29N5O2 | |
GC11122-5mg |
|
346673-06-1 |
TCS 2510
|
0 | C21H29N5O2 | |
GC11122-1mg |
|
346673-06-1 |
TCS 2510
|
0 | C21H29N5O2 | |